Demographic and Reversibility Data from Clinical Trials in COPD

Data on file: SLGA 4004, SLGA 4005, Chest 1994; 105:1411-1419.

Chest 1999; 115;966-971.

Am J Respir Crit Care Med. Vol 165. p. 778-784, 2001.

Salmeterol Combivent Formoterol

(n=816) (n=1067) (n=780)

Age 63 64 63

% male 68 69 75

Pack yr 63 na 42

FEV1 L (% pred) 1.25 (40) 0.99 (36) 1.3 (45)

% Pts Rev 62 68-73 42

Previous slide

Next slide

Back to first slide

View graphic version